FIRSTSTRING RES INC has a total of 24 patent applications. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are ACER THERAPEUTICS INC, IMMUNOFRONTIER INC and CHEN ANDREW XIAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Israel | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Mexico | 2 | |
#8 | United States | 2 | |
#9 | Brazil | 1 | |
#10 | Hong Kong | 1 | |
#11 | India | 1 | |
#12 | New Zealand | 1 | |
#13 | Singapore | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Basic materials chemistry | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Preservation of human bodies | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Ghatnekar Gautam | 15 |
#2 | Gautam Ghatnekar | 4 |
#3 | Ghatnekar Gautam S | 3 |
#4 | Grek Christina L | 1 |
Publication | Filing date | Title |
---|---|---|
US2021007347A1 | Compositions and methods for preserving organ transplants | |
WO2020056144A1 | Nanoparticle formulations and methods of use for alpha connexin c-terminal peptides | |
KR20190135470A | Compositions and methods for preventing radiation injury and promoting tissue regeneration | |
NZ629769A | Topical gels containing alpha connexin c-terminal (act) peptides |